# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-25-180865
Filing Date
2025-08-14
Accepted
2025-08-14 16:46:26
Documents
90
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K/A | eldn-20241231.htm iXBRL | 10-K/A | 4326476
2 | EX-23.1 | eldn-ex23_1.htm | EX-23.1 | 6469
3 | EX-23.2 | eldn-ex23_2.htm | EX-23.2 | 5499
4 | EX-31.3 | eldn-ex31_3.htm | EX-31.3 | 18302
5 | EX-31.4 | eldn-ex31_4.htm | EX-31.4 | 18555
6 | EX-32.3 | eldn-ex32_3.htm | EX-32.3 | 9815
7 | EX-32.4 | eldn-ex32_4.htm | EX-32.4 | 9639
8 | GRAPHIC | img117130267_0.jpg | GRAPHIC | 868165
9 | GRAPHIC | img117130267_1.jpg | GRAPHIC | 273026
10 | GRAPHIC | img117130267_2.jpg | GRAPHIC | 154264
11 | GRAPHIC | img117130267_3.jpg | GRAPHIC | 119803
| Complete submission text file | 0001193125-25-180865.txt |  | 19949453

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | eldn-20241231.xsd | EX-101.SCH | 1579494
93 | EXTRACTED XBRL INSTANCE DOCUMENT | eldn-20241231_htm.xml | XML | 3790526

Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36620 | Film No.: 251220372
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)